Serial Number
77847233
Owner
NANTHEALTH, INC.Attorney
David J. Byer and Sara E. YevicsFirst Use Date
May 5, 2010
Filing Date
Oct 13, 2009
EVIDENCE-BASED INTELLIGENCE FOR IMPROVED OUTCOMES Trademark
Serial Number: 77847233 • Registration: 3941494
Trademark Classes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 45 - Legal & Security Services
Legal services; security services for the protection of property and individuals
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Attorney of Record
David J. Byer and Sara E. YevicsTrademark Details
Filing Date
October 13, 2009
Registration Date
April 5, 2011
First Use Anywhere
May 5, 2010
First Use in Commerce
May 5, 2010
Published for Opposition
April 13, 2010
Cancellation Date
November 10, 2017
Goods & Services
Consulting services to reduce costs and unnecessary utilization in the treatment of critical illnesses
Case management services, namely, coordination of services among medical providers, insurers, and patients with critical illnesses
Managed health care services; consulting services in the field of health, namely, consulting services among medical providers, insurers, and patients with critical illnesses; providing medical information, consultancy, and advisory services; medical counseling services for patients and their families; consulting services in the field of health, namely, medical treatment plan review and validation; tracking patient treatment, progress, concerns, and compliance issues, namely, maintaining a database for others in the field of critical illness treatment information and featuring inputting and collection of data and information all for treatment and diagnostic purposes
Providing temporary use of a non-downloadable web-based software application for ensuring the selection of and reimbursement for appropriate treatments for critical illnesses
